サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1365975

世界の慢性腎臓病治療薬市場：考察と予測 (2029年まで)

Global Drugs to Treat Chronic Kidney Disease Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の慢性腎臓病治療薬市場：考察と予測 (2029年まで)
出版日: 2023年10月20日
発行: QYResearch
ページ情報: 英文 115 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、慢性腎臓病治療薬 (Drugs to Treat Chronic Kidney Disease) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の慢性腎臓病治療薬の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Calcimimetics
    • Vitamin D
    • Sterols
    • Potassium Binders
    • Calcium-Based Phosphate Binders
  • 市場：用途別
    • 世界の慢性腎臓病治療薬の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の慢性腎臓病治療薬の市場展望 (2018-2029)
  • 世界の慢性腎臓病治療薬の市場成長トレンド：地域別
    • 慢性腎臓病治療薬 市場規模：地域別: 2018 VS 2022 VS 2029
    • 慢性腎臓病治療薬の市場規模実績：地域別 (2018-2023)
    • 慢性腎臓病治療薬の市場規模予測：地域別 (2024-2029)
  • 慢性腎臓病治療薬 市場動向
    • 慢性腎臓病治療薬 業界動向
    • 慢性腎臓病治療薬 市場の促進要因
    • 慢性腎臓病治療薬 市場の課題
    • 慢性腎臓病治療薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 慢性腎臓病治療薬 ：競合別
    • 世界の慢性腎臓病治療薬の収益：企業別 (2018-2023)
    • 世界の慢性腎臓病治療薬の収益シェア：企業別 (2018-2023)
  • 世界の慢性腎臓病治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 慢性腎臓病治療薬, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の慢性腎臓病治療薬 市場集中度
    • 世界の慢性腎臓病治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 慢性腎臓病治療薬の収益 2022
  • 世界の主要企業 慢性腎臓病治療薬 本社 および提供地域
  • 世界の主要企業 慢性腎臓病治療薬, 製品およびアプリケーション
  • 世界の主要企業 慢性腎臓病治療薬, 業界参入時期
  • M&A, 拡張計画

第4章 慢性腎臓病治療薬 内訳データ：タイプ別

  • 世界の慢性腎臓病治療薬の市場規模実績：タイプ別 (2018-2023)
  • 世界の慢性腎臓病治療薬の市場規模予測：タイプ別 (2024-2029)

第5章 慢性腎臓病治療薬 内訳データ：用途別

  • 世界の慢性腎臓病治療薬の市場規模実績：用途別 (2018-2023)
  • 世界の慢性腎臓病治療薬の市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の慢性腎臓病治療薬 市場規模 (2018-2029)
  • 北米の慢性腎臓病治療薬 市場規模：タイプ別
    • 北米の慢性腎臓病治療薬 市場規模：タイプ別 (2018-2023)
    • 北米の慢性腎臓病治療薬 市場規模：タイプ別 (2024-2029)
    • 北米の慢性腎臓病治療薬の市場シェア：タイプ別 (2018-2029)
  • 北米の慢性腎臓病治療薬 市場規模：用途別
    • 北米の慢性腎臓病治療薬 市場規模：用途別 (2018-2023)
    • 北米の慢性腎臓病治療薬 市場規模：用途別 (2024-2029)
    • 北米の慢性腎臓病治療薬の市場シェア：用途別 (2018-2029)
  • 北米の慢性腎臓病治療薬 市場規模：国別
    • 北米の慢性腎臓病治療薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の慢性腎臓病治療薬 市場規模：国別 (2018-2023)
    • 北米の慢性腎臓病治療薬 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の慢性腎臓病治療薬 市場規模 (2018-2029)
  • 欧州の慢性腎臓病治療薬 市場規模：タイプ別
    • 欧州の慢性腎臓病治療薬 市場規模：タイプ別 (2018-2023)
    • 欧州の慢性腎臓病治療薬 市場規模：タイプ別 (2024-2029)
    • 欧州の慢性腎臓病治療薬の市場シェア：タイプ別 (2018-2029)
  • 欧州の慢性腎臓病治療薬 市場規模：用途別
    • 欧州の慢性腎臓病治療薬 市場規模：用途別 (2018-2023)
    • 欧州の慢性腎臓病治療薬 市場規模：用途別 (2024-2029)
    • 欧州の慢性腎臓病治療薬の市場シェア：用途別 (2018-2029)
  • 欧州の慢性腎臓病治療薬 市場規模：国別
    • 欧州の慢性腎臓病治療薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の慢性腎臓病治療薬 市場規模：国別 (2018-2023)
    • 欧州の慢性腎臓病治療薬 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の慢性腎臓病治療薬 市場規模 (2018-2029)
  • 中国の慢性腎臓病治療薬 市場規模：タイプ別
    • 中国の慢性腎臓病治療薬 市場規模：タイプ別 (2018-2023)
    • 中国の慢性腎臓病治療薬 市場規模：タイプ別 (2024-2029)
    • 中国の慢性腎臓病治療薬の市場シェア：タイプ別 (2018-2029)
  • 中国の慢性腎臓病治療薬 市場規模：用途別
    • 中国の慢性腎臓病治療薬 市場規模：用途別 (2018-2023)
    • 中国の慢性腎臓病治療薬 市場規模：用途別 (2024-2029)
    • 中国の慢性腎臓病治療薬の市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 慢性腎臓病治療薬 市場規模 (2018-2029)
  • アジア地域 慢性腎臓病治療薬 市場規模：タイプ別
    • アジア地域 慢性腎臓病治療薬 市場規模：タイプ別 (2018-2023)
    • アジア地域 慢性腎臓病治療薬 市場規模：タイプ別 (2024-2029)
    • アジア地域 慢性腎臓病治療薬の市場シェア：タイプ別 (2018-2029)
  • アジア地域 慢性腎臓病治療薬 市場規模：用途別
    • アジア地域 慢性腎臓病治療薬 市場規模：用途別 (2018-2023)
    • アジア地域 慢性腎臓病治療薬 市場規模：用途別 (2024-2029)
    • アジア地域 慢性腎臓病治療薬の市場シェア：用途別 (2018-2029)
  • アジア地域 慢性腎臓病治療薬 市場規模：地域別
    • アジア地域 慢性腎臓病治療薬 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 慢性腎臓病治療薬 市場規模：地域別 (2018-2023)
    • アジア地域 慢性腎臓病治療薬 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：タイプ別
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬の市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：用途別
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬の市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：国別
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 慢性腎臓病治療薬 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Eli Lilly and Company
  • C.H. Boehringer Sohn AG & Co. KG
  • Amgen Inc.
  • Novo Nordisk A/S
  • Teva Pharmaceutical Industries Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Company Limited

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Calcimimetics
  • Table 3. Key Players of Vitamin D
  • Table 4. Key Players of Sterols
  • Table 5. Key Players of Potassium Binders
  • Table 6. Key Players of Calcium-Based Phosphate Binders
  • Table 7. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 8. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 9. Global Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2023) & (US$ Million)
  • Table 10. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2018-2023)
  • Table 11. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 12. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2024-2029)
  • Table 13. Drugs to Treat Chronic Kidney Disease Market Trends
  • Table 14. Drugs to Treat Chronic Kidney Disease Market Drivers
  • Table 15. Drugs to Treat Chronic Kidney Disease Market Challenges
  • Table 16. Drugs to Treat Chronic Kidney Disease Market Restraints
  • Table 17. Global Drugs to Treat Chronic Kidney Disease Revenue by Players (2018-2023) & (US$ Million)
  • Table 18. Global Drugs to Treat Chronic Kidney Disease Revenue Share by Players (2018-2023)
  • Table 19. Global Top Drugs to Treat Chronic Kidney Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2022)
  • Table 20. Global Drugs to Treat Chronic Kidney Disease Industry Ranking 2021 VS 2022 VS 2023
  • Table 21. Global 5 Largest Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue (CR5 and HHI) & (2018-2023)
  • Table 22. Global Key Players of Drugs to Treat Chronic Kidney Disease, Headquarters and Area Served
  • Table 23. Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
  • Table 24. Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (US$ Million)
  • Table 27. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2018-2023)
  • Table 28. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 29. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2024-2029)
  • Table 30. Global Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (US$ Million)
  • Table 31. Global Drugs to Treat Chronic Kidney Disease Revenue Share by Application (2018-2023)
  • Table 32. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 33. Global Drugs to Treat Chronic Kidney Disease Revenue Share by Application (2024-2029)
  • Table 34. North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (US$ Million)
  • Table 35. North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
  • Table 36. North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (US$ Million)
  • Table 37. North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
  • Table 38. North America Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 39. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2023) & (US$ Million)
  • Table 40. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029) & (US$ Million)
  • Table 41. Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (US$ Million)
  • Table 42. Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
  • Table 43. Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (US$ Million)
  • Table 44. Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
  • Table 45. Europe Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 46. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2023) & (US$ Million)
  • Table 47. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029) & (US$ Million)
  • Table 48. China Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (US$ Million)
  • Table 49. China Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
  • Table 50. China Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (US$ Million)
  • Table 51. China Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
  • Table 52. Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (US$ Million)
  • Table 53. Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
  • Table 54. Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (US$ Million)
  • Table 55. Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
  • Table 56. Asia Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 57. Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2023) & (US$ Million)
  • Table 58. Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 64. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2023) & (US$ Million)
  • Table 65. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029) & (US$ Million)
  • Table 66. Pfizer Inc. Company Details
  • Table 67. Pfizer Inc. Business Overview
  • Table 68. Pfizer Inc. Drugs to Treat Chronic Kidney Disease Product
  • Table 69. Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 70. Pfizer Inc. Recent Developments
  • Table 71. Johnson & Johnson Company Details
  • Table 72. Johnson & Johnson Business Overview
  • Table 73. Johnson & Johnson Drugs to Treat Chronic Kidney Disease Product
  • Table 74. Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 75. Johnson & Johnson Recent Developments
  • Table 76. AbbVie Inc. Company Details
  • Table 77. AbbVie Inc. Business Overview
  • Table 78. AbbVie Inc. Drugs to Treat Chronic Kidney Disease Product
  • Table 79. AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 80. AbbVie Inc. Recent Developments
  • Table 81. Bayer AG Company Details
  • Table 82. Bayer AG Business Overview
  • Table 83. Bayer AG Drugs to Treat Chronic Kidney Disease Product
  • Table 84. Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 85. Bayer AG Recent Developments
  • Table 86. Novartis AG Company Details
  • Table 87. Novartis AG Business Overview
  • Table 88. Novartis AG Drugs to Treat Chronic Kidney Disease Product
  • Table 89. Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 90. Novartis AG Recent Developments
  • Table 91. Sanofi SA Company Details
  • Table 92. Sanofi SA Business Overview
  • Table 93. Sanofi SA Drugs to Treat Chronic Kidney Disease Product
  • Table 94. Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 95. Sanofi SA Recent Developments
  • Table 96. Bristol-Myers Squibb Company Company Details
  • Table 97. Bristol-Myers Squibb Company Business Overview
  • Table 98. Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Product
  • Table 99. Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 100. Bristol-Myers Squibb Company Recent Developments
  • Table 101. AstraZeneca plc Company Details
  • Table 102. AstraZeneca plc Business Overview
  • Table 103. AstraZeneca plc Drugs to Treat Chronic Kidney Disease Product
  • Table 104. AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 105. AstraZeneca plc Recent Developments
  • Table 106. Eli Lilly and Company Company Details
  • Table 107. Eli Lilly and Company Business Overview
  • Table 108. Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Product
  • Table 109. Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 110. Eli Lilly and Company Recent Developments
  • Table 111. C.H. Boehringer Sohn AG & Co. KG Company Details
  • Table 112. C.H. Boehringer Sohn AG & Co. KG Business Overview
  • Table 113. C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Product
  • Table 114. C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 115. C.H. Boehringer Sohn AG & Co. KG Recent Developments
  • Table 116. Amgen Inc. Company Details
  • Table 117. Amgen Inc. Business Overview
  • Table 118. Amgen Inc. Drugs to Treat Chronic Kidney Disease Product
  • Table 119. Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 120. Amgen Inc. Recent Developments
  • Table 121. Novo Nordisk A/S Company Details
  • Table 122. Novo Nordisk A/S Business Overview
  • Table 123. Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Product
  • Table 124. Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 125. Novo Nordisk A/S Recent Developments
  • Table 126. Teva Pharmaceutical Industries Ltd. Company Details
  • Table 127. Teva Pharmaceutical Industries Ltd. Business Overview
  • Table 128. Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Product
  • Table 129. Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 130. Teva Pharmaceutical Industries Ltd. Recent Developments
  • Table 131. Otsuka Pharmaceutical Co. Ltd. Company Details
  • Table 132. Otsuka Pharmaceutical Co. Ltd. Business Overview
  • Table 133. Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Product
  • Table 134. Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 135. Otsuka Pharmaceutical Co. Ltd. Recent Developments
  • Table 136. Takeda Pharmaceutical Company Limited Company Details
  • Table 137. Takeda Pharmaceutical Company Limited Business Overview
  • Table 138. Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Product
  • Table 139. Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023) & (US$ Million)
  • Table 140. Takeda Pharmaceutical Company Limited Recent Developments
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Drugs to Treat Chronic Kidney Disease Market Share by Type: 2022 VS 2029
  • Figure 3. Calcimimetics Features
  • Figure 4. Vitamin D Features
  • Figure 5. Sterols Features
  • Figure 6. Potassium Binders Features
  • Figure 7. Calcium-Based Phosphate Binders Features
  • Figure 8. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 9. Global Drugs to Treat Chronic Kidney Disease Market Share by Application: 2022 VS 2029
  • Figure 10. Hospital Pharmacies Case Studies
  • Figure 11. Online Pharmacies Case Studies
  • Figure 12. Retail Pharmacies Case Studies
  • Figure 13. Drugs to Treat Chronic Kidney Disease Report Years Considered
  • Figure 14. Global Drugs to Treat Chronic Kidney Disease Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 15. Global Drugs to Treat Chronic Kidney Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 16. Global Drugs to Treat Chronic Kidney Disease Market Share by Region: 2022 VS 2029
  • Figure 17. Global Drugs to Treat Chronic Kidney Disease Market Share by Players in 2022
  • Figure 18. Global Top Drugs to Treat Chronic Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2022)
  • Figure 19. The Top 10 and 5 Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue in 2022
  • Figure 20. North America Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. North America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • Figure 22. North America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • Figure 23. North America Drugs to Treat Chronic Kidney Disease Market Share by Country (2018-2029)
  • Figure 24. United States Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Canada Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Europe Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
  • Figure 27. Europe Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • Figure 28. Europe Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • Figure 29. Europe Drugs to Treat Chronic Kidney Disease Market Share by Country (2018-2029)
  • Figure 30. Germany Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. France Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. U.K. Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Italy Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Russia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Nordic Countries Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. China Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. China Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • Figure 38. China Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • Figure 39. Asia Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
  • Figure 40. Asia Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • Figure 41. Asia Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • Figure 42. Asia Drugs to Treat Chronic Kidney Disease Market Share by Region (2018-2029)
  • Figure 43. Japan Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. South Korea Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. China Taiwan Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Southeast Asia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. India Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Australia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size YoY (2018-2029) & (US$ Million)
  • Figure 50. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • Figure 52. Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Country (2018-2029)
  • Figure 53. Brazil Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Mexico Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Turkey Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Saudi Arabia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Israel Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. GCC Countries Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 59. Pfizer Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 60. Johnson & Johnson Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 61. AbbVie Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 62. Bayer AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 63. Novartis AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 64. Sanofi SA Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 66. AstraZeneca plc Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 67. Eli Lilly and Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 68. C.H. Boehringer Sohn AG & Co. KG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 69. Amgen Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 70. Novo Nordisk A/S Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 71. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 72. Otsuka Pharmaceutical Co. Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 73. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
  • Figure 74. Bottom-up and Top-down Approaches for This Report
  • Figure 75. Data Triangulation
  • Figure 76. Key Executives Interviewed
目次

This research report focuses on the Drugs to Treat Chronic Kidney Disease Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Calcimimetics
    • 1.2.3 Vitamin D
    • 1.2.4 Sterols
    • 1.2.5 Potassium Binders
    • 1.2.6 Calcium-Based Phosphate Binders
  • 1.3 Market by Application
    • 1.3.1 Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Online Pharmacies
    • 1.3.4 Retail Pharmacies
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Drugs to Treat Chronic Kidney Disease Market Perspective (2018-2029)
  • 2.2 Global Drugs to Treat Chronic Kidney Disease Growth Trends by Region
    • 2.2.1 Drugs to Treat Chronic Kidney Disease Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Drugs to Treat Chronic Kidney Disease Historic Market Size by Region (2018-2023)
    • 2.2.3 Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2024-2029)
  • 2.3 Drugs to Treat Chronic Kidney Disease Market Dynamics
    • 2.3.1 Drugs to Treat Chronic Kidney Disease Industry Trends
    • 2.3.2 Drugs to Treat Chronic Kidney Disease Market Drivers
    • 2.3.3 Drugs to Treat Chronic Kidney Disease Market Challenges
    • 2.3.4 Drugs to Treat Chronic Kidney Disease Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Drugs to Treat Chronic Kidney Disease by Players
    • 3.1.1 Global Drugs to Treat Chronic Kidney Disease Revenue by Players (2018-2023)
    • 3.1.2 Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Players (2018-2023)
  • 3.2 Global Drugs to Treat Chronic Kidney Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Drugs to Treat Chronic Kidney Disease, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio
    • 3.4.1 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drugs to Treat Chronic Kidney Disease Revenue in 2022
  • 3.5 Global Key Players of Drugs to Treat Chronic Kidney Disease Head office and Area Served
  • 3.6 Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
  • 3.7 Global Key Players of Drugs to Treat Chronic Kidney Disease, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs to Treat Chronic Kidney Disease Breakdown Data by Type

  • 4.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Type (2018-2023)
  • 4.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2024-2029)

5 Drugs to Treat Chronic Kidney Disease Breakdown Data by Application

  • 5.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Application (2018-2023)
  • 5.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  • 6.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Type
    • 6.2.1 North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023)
    • 6.2.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
    • 6.2.3 North America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • 6.3 North America Drugs to Treat Chronic Kidney Disease Market Size by Application
    • 6.3.1 North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023)
    • 6.3.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
    • 6.3.3 North America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • 6.4 North America Drugs to Treat Chronic Kidney Disease Market Size by Country
    • 6.4.1 North America Drugs to Treat Chronic Kidney Disease Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2023)
    • 6.4.3 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  • 7.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Type
    • 7.2.1 Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023)
    • 7.2.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
    • 7.2.3 Europe Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • 7.3 Europe Drugs to Treat Chronic Kidney Disease Market Size by Application
    • 7.3.1 Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023)
    • 7.3.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
    • 7.3.3 Europe Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • 7.4 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country
    • 7.4.1 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2023)
    • 7.4.3 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  • 8.2 China Drugs to Treat Chronic Kidney Disease Market Size by Type
    • 8.2.1 China Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023)
    • 8.2.2 China Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
    • 8.2.3 China Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • 8.3 China Drugs to Treat Chronic Kidney Disease Market Size by Application
    • 8.3.1 China Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023)
    • 8.3.2 China Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
    • 8.3.3 China Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  • 9.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Type
    • 9.2.1 Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023)
    • 9.2.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
    • 9.2.3 Asia Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • 9.3 Asia Drugs to Treat Chronic Kidney Disease Market Size by Application
    • 9.3.1 Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023)
    • 9.3.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
    • 9.3.3 Asia Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • 9.4 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region
    • 9.4.1 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2023)
    • 9.4.3 Asia Drugs to Treat Chronic Kidney Disease Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Pfizer Inc.
    • 11.1.1 Pfizer Inc. Company Details
    • 11.1.2 Pfizer Inc. Business Overview
    • 11.1.3 Pfizer Inc. Drugs to Treat Chronic Kidney Disease Introduction
    • 11.1.4 Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.1.5 Pfizer Inc. Recent Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Company Details
    • 11.2.2 Johnson & Johnson Business Overview
    • 11.2.3 Johnson & Johnson Drugs to Treat Chronic Kidney Disease Introduction
    • 11.2.4 Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.2.5 Johnson & Johnson Recent Developments
  • 11.3 AbbVie Inc.
    • 11.3.1 AbbVie Inc. Company Details
    • 11.3.2 AbbVie Inc. Business Overview
    • 11.3.3 AbbVie Inc. Drugs to Treat Chronic Kidney Disease Introduction
    • 11.3.4 AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.3.5 AbbVie Inc. Recent Developments
  • 11.4 Bayer AG
    • 11.4.1 Bayer AG Company Details
    • 11.4.2 Bayer AG Business Overview
    • 11.4.3 Bayer AG Drugs to Treat Chronic Kidney Disease Introduction
    • 11.4.4 Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.4.5 Bayer AG Recent Developments
  • 11.5 Novartis AG
    • 11.5.1 Novartis AG Company Details
    • 11.5.2 Novartis AG Business Overview
    • 11.5.3 Novartis AG Drugs to Treat Chronic Kidney Disease Introduction
    • 11.5.4 Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.5.5 Novartis AG Recent Developments
  • 11.6 Sanofi SA
    • 11.6.1 Sanofi SA Company Details
    • 11.6.2 Sanofi SA Business Overview
    • 11.6.3 Sanofi SA Drugs to Treat Chronic Kidney Disease Introduction
    • 11.6.4 Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.6.5 Sanofi SA Recent Developments
  • 11.7 Bristol-Myers Squibb Company
    • 11.7.1 Bristol-Myers Squibb Company Company Details
    • 11.7.2 Bristol-Myers Squibb Company Business Overview
    • 11.7.3 Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Introduction
    • 11.7.4 Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.7.5 Bristol-Myers Squibb Company Recent Developments
  • 11.8 AstraZeneca plc
    • 11.8.1 AstraZeneca plc Company Details
    • 11.8.2 AstraZeneca plc Business Overview
    • 11.8.3 AstraZeneca plc Drugs to Treat Chronic Kidney Disease Introduction
    • 11.8.4 AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.8.5 AstraZeneca plc Recent Developments
  • 11.9 Eli Lilly and Company
    • 11.9.1 Eli Lilly and Company Company Details
    • 11.9.2 Eli Lilly and Company Business Overview
    • 11.9.3 Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Introduction
    • 11.9.4 Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.9.5 Eli Lilly and Company Recent Developments
  • 11.10 C.H. Boehringer Sohn AG & Co. KG
    • 11.10.1 C.H. Boehringer Sohn AG & Co. KG Company Details
    • 11.10.2 C.H. Boehringer Sohn AG & Co. KG Business Overview
    • 11.10.3 C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Introduction
    • 11.10.4 C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.10.5 C.H. Boehringer Sohn AG & Co. KG Recent Developments
  • 11.11 Amgen Inc.
    • 11.11.1 Amgen Inc. Company Details
    • 11.11.2 Amgen Inc. Business Overview
    • 11.11.3 Amgen Inc. Drugs to Treat Chronic Kidney Disease Introduction
    • 11.11.4 Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.11.5 Amgen Inc. Recent Developments
  • 11.12 Novo Nordisk A/S
    • 11.12.1 Novo Nordisk A/S Company Details
    • 11.12.2 Novo Nordisk A/S Business Overview
    • 11.12.3 Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Introduction
    • 11.12.4 Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.12.5 Novo Nordisk A/S Recent Developments
  • 11.13 Teva Pharmaceutical Industries Ltd.
    • 11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
    • 11.13.3 Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Introduction
    • 11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  • 11.14 Otsuka Pharmaceutical Co. Ltd.
    • 11.14.1 Otsuka Pharmaceutical Co. Ltd. Company Details
    • 11.14.2 Otsuka Pharmaceutical Co. Ltd. Business Overview
    • 11.14.3 Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Introduction
    • 11.14.4 Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.14.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments
  • 11.15 Takeda Pharmaceutical Company Limited
    • 11.15.1 Takeda Pharmaceutical Company Limited Company Details
    • 11.15.2 Takeda Pharmaceutical Company Limited Business Overview
    • 11.15.3 Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Introduction
    • 11.15.4 Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2018-2023)
    • 11.15.5 Takeda Pharmaceutical Company Limited Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details